These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8399919

  • 1. Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erythromycin in vitro.
    Kenny GE, Cartwright FD.
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S215-8. PubMed ID: 8399919
    [Abstract] [Full Text] [Related]

  • 2. Comparison of agar versus broth dilution techniques for determining antibiotic susceptibilities of Ureaplasma urealyticum.
    Waites KB, Figarola TA, Schmid T, Crabb DM, Duffy LB, Simecka JW.
    Diagn Microbiol Infect Dis; 1991 Aug; 14(3):265-71. PubMed ID: 1889178
    [Abstract] [Full Text] [Related]

  • 3. Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Samra Z, Rosenberg S, Dan M.
    J Chemother; 2011 Apr; 23(2):77-9. PubMed ID: 21571622
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin.
    Robertson JA, Coppola JE, Heisler OR.
    Antimicrob Agents Chemother; 1981 Jul; 20(1):53-8. PubMed ID: 7283415
    [Abstract] [Full Text] [Related]

  • 7. Assessment of antibiotic susceptibility of Ureaplasma urealyticum from prostitutes and outpatient clinic patients using the E-test and agar dilution method.
    Cakan H, Polat E, Kocazeybek B, Ocal P, Cepni I, Aslan M, Salihoğlu F, Altaş K.
    Chemotherapy; 2003 May; 49(1-2):39-43. PubMed ID: 12714809
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.
    Kanamoto Y, Miyake Y, Suginaka H, Usui T.
    Chemotherapy; 1991 May; 37(4):256-9. PubMed ID: 1790724
    [Abstract] [Full Text] [Related]

  • 9. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
    Suzaki K.
    Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
    [Abstract] [Full Text] [Related]

  • 10. Ureaplasma urealyticum: subcultures invalid for antibiotic susceptibility tests.
    Kundsin RB, Poulin SA.
    Diagn Microbiol Infect Dis; 1985 Jul; 3(4):329-36. PubMed ID: 4028663
    [Abstract] [Full Text] [Related]

  • 11. [In vitro activity of sparfloxacin against mycoplasmas].
    Renaudin H, Bebear C.
    Pathol Biol (Paris); 1992 May; 40(5):450-4. PubMed ID: 1323094
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland.
    Schneider SC, Tinguely R, Droz S, Hilty M, Donà V, Bodmer T, Endimiani A.
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6026-31. PubMed ID: 26195516
    [Abstract] [Full Text] [Related]

  • 13. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M, Hallander HO.
    Scand J Infect Dis Suppl; 1988 Oct; 53():12-7. PubMed ID: 2843982
    [Abstract] [Full Text] [Related]

  • 14. Differences in biofilm development and antibiotic susceptibility among clinical Ureaplasma urealyticum and Ureaplasma parvum isolates.
    García-Castillo M, Morosini MI, Gálvez M, Baquero F, del Campo R, Meseguer MA.
    J Antimicrob Chemother; 2008 Nov; 62(5):1027-30. PubMed ID: 18753188
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antimicrobial activity of Manuka honey against antibiotic-resistant strains of the cell wall-free bacteria Ureaplasma parvum and Ureaplasma urealyticum.
    Hillitt KL, Jenkins RE, Spiller OB, Beeton ML.
    Lett Appl Microbiol; 2017 Mar; 64(3):198-202. PubMed ID: 27992658
    [Abstract] [Full Text] [Related]

  • 17. Effects of environmental factors on the in vitro potency of azithromycin.
    Retsema JA, Brennan LA, Girard AE.
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):834-42. PubMed ID: 1662627
    [Abstract] [Full Text] [Related]

  • 18. Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection.
    Waites KB, Sims PJ, Crouse DT, Geerts MH, Shoup RE, Hamrick WB, Duffy LB, Cassell GH.
    Pediatr Infect Dis J; 1994 Apr; 13(4):287-93. PubMed ID: 8036045
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of in vitro antimicrobial activity of cefazolin alone and in combination with cefmetazole or flomoxef using agar dilution method and disk diffusion method].
    Matsuo K, Uete T.
    Jpn J Antibiot; 1992 Oct; 45(10):1253-66. PubMed ID: 1479676
    [Abstract] [Full Text] [Related]

  • 20. Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin.
    Aydin D, Küçükbasmaci O, Gonullu N, Aktaş Z.
    Chemotherapy; 2005 May; 51(2-3):89-92. PubMed ID: 15886468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.